Physician profile
Henry Chill
NPI 1114597846
$16,935.05
in general payments reported to CMS, 2019-2025
10 companies · $26.33 in 2025
The $26.33 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $739 · 2022: $11K · 2023: $840 · 2024: $4,526 · 2025: $26.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,347 · Food and Beverage: $2,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,347.04 |
| Food and Beverage | $2,044.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,661.76 | 2021-2024 | Interstim |
| Boston Scientific Corporation | $2,489.22 | 2021-2024 | Solyx Sis System, Advantage System, Upsylon |
| Coloplast Corp | $1,714.16 | 2023-2024 | Altis |
| Axonics, INC. | $1,672.31 | 2023-2024 | Axonics, Bulkamid |
| Urovant Sciences INC | $148.90 | 2022 | |
| 180 Medical, INC. | $70.93 | 2022-2023 | Gentlecath |
| Convatec INC. | $63.78 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $47.68 | 2024 | Exparel |
| Abbvie INC. | $47.55 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $18.76 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Chill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.